These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2977928)

  • 1. Kidney disease in KK mice: effect of glyburide.
    Camerini-Davalos RA; Reddi AS
    Adv Exp Med Biol; 1988; 246():297-303. PubMed ID: 2977928
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic glomerulosclerosis in KK mice and its prevention by glyburide and pyridinolcarbamate.
    Camerini-Davalos RA; Reddi AS; Ehrenreich TH; Strugatz LH; Oppermann W
    Adv Exp Med Biol; 1979; 119():387-400. PubMed ID: 115232
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetic microangiopathy in KK mice. V. Effect of early glyburide treatment of kidney glucosyltransferase activity.
    Reddi AS; Oppermann W; Velasco C; Camerini-Davalos RA
    Exp Mol Pathol; 1978 Dec; 29(3):442-7. PubMed ID: 102528
    [No Abstract]   [Full Text] [Related]  

  • 4. Kidney disease in KK mice: effect of glipizide.
    Reddi AS; Velasco CA; Khan MY; Bloodworth JM; Camerini-Davalos RA
    Adv Exp Med Biol; 1988; 246():305-12. PubMed ID: 3250259
    [No Abstract]   [Full Text] [Related]  

  • 5. Kidney disease in KK mice: effect of insulin.
    Camerini-Davalos RA; Reddi AS; Wehner H; Velasco CA
    Adv Exp Med Biol; 1988; 246():333-7. PubMed ID: 3074664
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetic microangiopathy in KK mice. VI. Effect of glycemic control on renal glycoprotein metabolism and established glomerulosclerosis.
    Reddi AS; Velasco CA; Reddy PR; Khan MY; Camerini-Davalos RA
    Exp Mol Pathol; 1990 Oct; 53(2):140-51. PubMed ID: 2148155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on biological characteristics of spontaneous diabetic KK mice].
    Chen QM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Dec; 10(6):416-20. PubMed ID: 2978397
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of glibenclamide on the spontaneous evolution of genetically determined diabetes mellitus in C57BL/KsJY db+/+db mice].
    Poltorak VV; Gladkikh AI; Blokh KO; Brindak OI; Berestovskaia EV; Tur MI
    Farmakol Toksikol; 1991; 54(1):34-7. PubMed ID: 1907244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymosin β4 attenuates early diabetic nephropathy in a mouse model of type 2 diabetes mellitus.
    Zhu J; Su LP; Zhou Y; Ye L; Lee KO; Ma JH
    Am J Ther; 2015; 22(2):141-6. PubMed ID: 23846524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotin supplementation improves glucose and insulin tolerances in genetically diabetic KK mice.
    Reddi A; DeAngelis B; Frank O; Lasker N; Baker H
    Life Sci; 1988; 42(13):1323-30. PubMed ID: 3280936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney disease in KK mice: structural, biochemical and functional relationships.
    Reddi AS; Wehner H; Khan MY; Camerini-Davalos RA
    Adv Exp Med Biol; 1988; 246():135-45. PubMed ID: 2854953
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypoglycemic activity of Erythrina variegata leaf in streptozotocin-induced diabetic rats.
    Kumar A; Lingadurai S; Shrivastava TP; Bhattacharya S; Haldar PK
    Pharm Biol; 2011 Jun; 49(6):577-82. PubMed ID: 21281246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence of changes in KK mouse nephropathy.
    Wehner H
    Adv Exp Med Biol; 1988; 246():147-56. PubMed ID: 3250252
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypoglycemic effects of leucodelphinidin derivative isolated from Ficus bengalensis (Linn).
    Geetha BS; Mathew BC; Augusti KT
    Indian J Physiol Pharmacol; 1994 Jul; 38(3):220-2. PubMed ID: 7814088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes treatment in patients with chronic kidney disease].
    Süfke S; Steinhoff J; Schütt M
    Dtsch Med Wochenschr; 2013 May; 138(21):1109-18; quiz 1119-22. PubMed ID: 23677506
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
    Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
    Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antidiabetic activity of aloes: preliminary clinical and experimental observations.
    Ghannam N; Kingston M; Al-Meshaal IA; Tariq M; Parman NS; Woodhouse N
    Horm Res; 1986; 24(4):288-94. PubMed ID: 3096865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic microangiopathy in KK mice. II. Suppression of Glomerulosclerosis by pyridinolcarbamate.
    Reddi AS; Oppermann W; Velasco CA; Camerini-Davalos RA
    Exp Mol Pathol; 1977 Apr; 26(2):325-39. PubMed ID: 852540
    [No Abstract]   [Full Text] [Related]  

  • 19. Antioxidant status in experimental type 2 diabetes mellitus: effects of glibenclamide and glipizide on various rat tissues.
    Tüzün S; Girgin FK; Sözmen EY; Menteş G; Ersöz B
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):436-41. PubMed ID: 10445412
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus.
    Yoshikawa Y; Ueda E; Miyake H; Sakurai H; Kojima Y
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1190-3. PubMed ID: 11243860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.